HIGHFDA DRUG

Major Pharmaceuticals Sulfamethoxazole and Trimethoprim 800 mg/160 mg 100-Tablets Recall 2025

Major Pharmaceuticals recalls sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets sold nationwide. A specific lot of packaging coil used in production was found to contain a microorganism in the packaging area, though no microorganism was detected on the tablets. Consumers should stop using the product and follow guidance from Major Pharmaceuticals or their healthcare provider.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 2, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
September 2, 2025
Hazard Level
HIGH
Brand
Sulfamethoxazole and Trimethoprim
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Sulfamethoxazole and Trimethoprim
Product type
Oral Antibiotic Tablet
Model numbers
Lot N02309, Exp 03/31/2027
UPC codes
0904-2725, 0904-2725-61
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 2, 2025

  2. Reported by FDA DRUG

    September 17, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories or your healthcare provider for guidance. Notification method: Letter

About This Product

This medication is a commonly prescribed antibiotic used to treat bacterial infections. The product comes in 800 mg/160 mg double-strength tablets and is Rx only.

Why This Is Dangerous

The hazard involves a foreign substance in packaging materials. A microorganism was detected in the auxiliary polyester coil used in packaging. The tablets themselves tested negative for microorganisms.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

The recall may cause temporary treatment delays for patients who were prescribed this antibiotic. Consumers should discontinue use and seek guidance from a clinician.

Practical Guidance

How to identify if yours is affected

  1. Check the NDC 0904-2725-61 on your bottle
  2. Review the carton for Lot N02309 and Exp 03/31/2027
  3. Confirm packaging coil origin from Amneal Pharmaceuticals LLC

Where to find product info

Recall notices and supplier statements should be available from Major Pharmaceuticals and the FDA enforcement database (D-0624-2025)

What timeline to expect

Recall processing outcomes and refunds or replacements, if offered, will follow the company’s recall procedure

If the manufacturer is unresponsive

  • Document all communications with the supplier
  • Consider contacting a healthcare provider or pharmacist for guidance
  • File a consumer product incident report with CPSC if you believe there is broader risk

How to prevent similar issues

  • Check NDC and lot numbers before taking any prescription medication
  • Follow recall notices promptly
  • Consult your healthcare provider before switching antibiotics

Documentation advice

Keep the recall letter, packaging, and any correspondence with the supplier for records

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg double-strength, 100 tablets per carton, unit-dose blister packs (10x10). Rx only. NDC 0904-2725-61. Distributor: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories. Packaged by Amneal Pharmaceuticals LLC. Sold nationwide in the USA. Recall date: 2025-09-02. Report date: 2025-09-17. Lot: N02309. Expiration: 03/31/2027.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 100 tablets per carton
  • Unit-dose blister packs (10x10)
  • Packaged by Amneal Pharmaceuticals LLC (packaging coil)

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Lot N02309
Exp 03/31/2027
UPC Codes
0904-2725
0904-2725-61
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more